drugset / Trial / NCT01443429

A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment

NCT01443429

Phase 1 Completed 24 enrolled Toray Industries, Inc
Non-randomizedSingle-groupOpen-label

Summary

The PK and safety profiles to be examined following a single oral administration of TRK-100STP (120 μg) under fasting conditions to patients with renal impairment and to subjects with normal renal function.

Timeline

Start
2011-08
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Beraprost Small molecule 120 ug Oral